Alison D. Schecter - 10 Dec 2021 Form 4 Insider Report for Axcella Health Inc.

Role
President - Research & Dev.
Signature
By: /s/ Paul Fehlner, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
10 Dec 2021
Net transactions value
$0
Form type
4
Filing time
14 Dec 2021, 16:21:11 UTC
Next filing
10 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXLA Stock Option (Right to Buy) Award $0 +25,000 $0.000000 25,000 10 Dec 2021 Common Stock 25,000 $5.57 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On March 17, 2021, the Reporting Person was granted an option to purchase 75,000 shares of AXLA common stock, which vest in three equal installments subject to the satisfaction of certain performance criteria. On December 10, 2021, the Issuer's Compensation Committee confirmed that the performance criteria had been met with regards to one installment, resulting in the vesting of 25,000 shares.